Considerable variations have been observed in the postnatal management and outcomes of hemolytic disease of the fetus and ...

A recent study showed limited data exist on the risks associated with anti-G during pregnancy, including the development of ...

A recent review showed Rhesus D (RhD)-negative red blood cell (RBC) products should be the first choice for women who require ...

In pregnancies at risk of hemolytic disease of the fetus and newborn (HDFN), amniocentesis is used to identify the fetus’s ...

A case report described an infant with concurrent HDFN and SMA who was succesfully treated with an onasemnogene abeparvovec infusion.